ホーム › 血液がん › ノースカロライナ › Durham
Durham、NCにおける血液がんの臨床試験
Durhamとその周辺地域（約30マイル以内）の拠点で、血液がんに関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
被験者募集中観察研究
- Duke University Medical Center, Durham
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
被験者募集中第3相
- Duke Cancer Center ( Site 0028), Durham
- University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 10マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Durham VA Medical Center, Durham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
被験者募集中第3相
- Quetzal Site 27, Chapel Hill · 10マイル先
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
被験者募集中第3相
- Duke University, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
被験者募集中第1/2相
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10マイル先
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
被験者募集中第3相
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10マイル先
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
被験者募集中
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10マイル先
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
被験者募集中第2相
- Lineberger Cancer, Chapel Hill · 10マイル先
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
被験者募集中
- 2400 Pratt Street, Durham
Implementation of an Oral Chemotherapy Adherence Intervention
被験者募集中
- UNC Chapel Hill, Chapel Hill · 10マイル先
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10マイル先
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
被験者募集中第1相
- University of North Carolina, Chapel Hill · 10マイル先
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
被験者募集中第1/2相
- Duke University Medical Center, Duke Cancer Center, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
被験者募集中第1相
- Duke Blood Cancer Center, Durham
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
被験者募集中早期第1相
- Duke University Health System, Durham
他の都市における血液がんの試験
- Houston, TX46件の研究
- New York City, NY26件の研究
- Boston, MA25件の研究
- Washington, DC19件の研究
- Seattle, WA18件の研究
- Baltimore, MD18件の研究
- Los Angeles, CA17件の研究
- Chicago, IL15件の研究
- Philadelphia, PA14件の研究
- Columbus, OH13件の研究
- Edison, NJ13件の研究
- Nashville, TN13件の研究
Durhamにおける他の研究
- 乳がん64件の研究
- がん（全種類）58件の研究
- 非小細胞肺癌39件の研究
- 多発性骨髄腫37件の研究
- 急性骨髄性白血病33件の研究
- 転移性癌33件の研究
- 前立腺がん32件の研究
- 肺がん32件の研究
- 大腸癌28件の研究
- 卵巣がん27件の研究
- 慢性リンパ性白血病27件の研究
- 心不全26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。